<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Considerations for Third-Line Therapy for Relapsed/Refractory DLBCL

Default sub title

minute read

by Targeted Oncology | July 31, 2023
placeholder

A 73-year-old woman presented with fever, headaches, and 7-lb unintentional weight loss​.

Topics: Press Coverage